Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

Study Site, Pittsburgh

Study Site, Philadelphia

Study Site, Paoli

Study Site, Silver Spring

Study Site, Hagerstown

Study Site, Huesca

Study Site, León

Study Site, Madrid

Study Site, Madrid

Study site, Madrid

Study Site, Harrisburg

Study Site, Asheville

Study Site, Jacksonville

Study Site, Franklin

Study Site, Lexington

Study Site, Reus

Study Site, Gallipolis

Study Site, Valladolid

Study Site, Chesterfield

Study Site, Troy

Study Site, Rochester

Study Site, Sioux Falls

Study Site, Topeka

Study Site, Houston

Study Site, Orange

Study Site, San Francisco

Study Site, Torrington

Study Site, Edmonton

Study Site, Abbotsford

Study Site, Kelowna

Study Site, Richmond Hill

Study Site, Palma

Study Site, Barcelona